EUVIMEDEUVIMED entdecken
Crossref

Integrated viral and immune monitoring in a prospective COVID-19 cohort from India

Sachee Agrawal, Nandini Kasarpalkar, Sayantani Ghosh, Gaurav Paradkar, Vaibhav Daund, Shilpa Bhowmick, Vidushi Chitalia, Priyanka Rao, Ashwini Sankpal, Varsha Kalsurkar, Karan Shah, Sameen Khan und 9 weitere

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiae187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Sachee Agrawal und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, B.Y.L. Nair Charitable Hospital, Mumbai 400008, India. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral, COVID-19 Vaccines. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Tata Sons, DBT Wellcome Trust India Alliance Team Science Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we report on longitudinal kinetics of cellular immune subsets following SARS-CoV-2 infection in a cohort of hospitalized individuals and evaluate the interplay of these profiles with infecting viral variants, humoral immunity including neutralizing responses, vaccination history, and clinical outcomes. A cohort of 121 SARS-CoV-2–infected individuals exhibiting varying disease states were prospectively evaluated for lymphopenic profiles, antiviral humoral responses and infecting viral variants for a period of up to 90 d spanning the period of February 2021 to January 2022 (second and third waves of infection). A total of 51 participants received at least 1 vaccine dose of indigenous vaccines (Covishield or Covaxin) prior to recruitment. When stratified in terms of mortality, B and natural killer cells, in contrast to the T cell compartment, did not recover from nadir levels in nonsurvivors who were largely unvaccinated. No discriminatory signature was identified for nonsurvivors in terms of anti-nucleocapsid or anti-S1-RBD IgG chemiluminescent immunoassay profiles including GenScript S1-RBD assays. Evaluation of sVCAM and sMAdCAM revealed opposing dynamics that correlated with disease severity and convalescence respectively. Viral variant analysis revealed Delta and Omicron variants to comprise the majority of the infections, which reflected national transmission kinetics during the period of recruitment. Our results demonstrate the importance of monitoring circulating biomarkers for convalescence as well as mortality in COVID-19 progression. Delta variants of SARS-CoV-2 clearly demonstrated increased pathogenicity and warrants sustained viral surveillance for re-emergence of these strains. Our findings with respect to vaccination advocate for continued vaccine development and administration of COVID-19 vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antibodies, ViralCOVID-19 VaccinesHumansIndiaMaleFemaleMiddle AgedAdultProspective StudiesImmunity, HumoralAgedAntibodies, NeutralizingMonitoring, ImmunologicVaccination

Stichwörter der Autor:innen

SARS-CoV-2biomarkersprospective immune monitoringvaccinationvariant analysis

Substanzen

Antibodies, ViralCOVID-19 VaccinesAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Microbiology, B.Y.L. Nair Charitable Hospital, Mumbai 400008, India.
  • Viral Immunopathogenesis Lab, Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Department of Molecular Immunology and Microbiology, Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.
  • Viral Research and Diagnostic Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai 400011, India.
  • Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai 400008, India.
  • Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health, Mumbai 400012, India.

ORCID-Profile: Vainav Patel

Förderung

  • Tata Sons
  • DBT Wellcome Trust India Alliance Team Science Grant

Zitieren

APA

Agrawal, S., Kasarpalkar, N., Ghosh, S., Paradkar, G., Daund, V., Bhowmick, S., Chitalia, V., Rao, P., Sankpal, A., Kalsurkar, V., Shah, K., Khan, S., Patil, A., Jagtap, D., Khandkar, O., Kaneria, M., Mahale, S. D., Sachdeva, G., Bhor, V. M., …, & Patel, V. (2024). Integrated viral and immune monitoring in a prospective COVID-19 cohort from India. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae187

Vancouver

Agrawal S, Kasarpalkar N, Ghosh S, Paradkar G, Daund V, Bhowmick S, et al. Integrated viral and immune monitoring in a prospective COVID-19 cohort from India. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae187

BibTeX
@article{Agrawal2024,
  author = {Agrawal, Sachee and Kasarpalkar, Nandini and Ghosh, Sayantani and Paradkar, Gaurav and Daund, Vaibhav and Bhowmick, Shilpa and Chitalia, Vidushi and Rao, Priyanka and Sankpal, Ashwini and Kalsurkar, Varsha and Shah, Karan and Khan, Sameen and Patil, Ashwini and Jagtap, Dhanashree and Khandkar, Omkar and Kaneria, Mala and Mahale, Smita D and Sachdeva, Geetanjali and Bhor, Vikrant M and Shastri, Jayanthi and Patel, Vainav},
  title = {Integrated viral and immune monitoring in a prospective COVID-19 cohort from India},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiae187}
}
Kostenlos starten →